CIJR | Canadian Institute for Jewish Research
L'institut Canadien de Recherches sur le Judaisme

Analysis

Jimmy Carter’s Personal Virtue Didn’t Ensure a Virtuous or Successful Presidency

Jonathan S. Tobin

JNS, Dec. 29, 2024

“For all of the applause he has received for his life as an ex-president, Carter’s animus against the Jewish state and willingness to use his moral standing and influence to besmirch it and aid the efforts of antisemitic hate-mongers and terrorists to undermine its existence is also part of his legacy.”

The stock of historical figures rises and falls with the changing times that follow them. That is especially true for American presidents. Admirers of former President Jimmy Carter are hoping that posterity will give him in a similar treatment.

The 39th president went into hospice at his Georgia home in February 2023. But remarkably, he lived for another 22 months with his wife, Rosalynn, dying in the interim. He even had the opportunity to cast one last vote for a successor (for Vice President Kamala Harris), dying this weekend at the age of 100. That makes him the longest-living president in U.S. history. And since he left office nearly 44 years ago, his was the longest post-presidency as well. More than one out of five Americans were born after he left the White House in 1981. In the intervening decades, the memories of those who were alive then may have dimmed.

That is part of the reason why the campaign to revive his reputation has already had such success. It was already in full swing when he went into hospice as articles and opinion pieces boosting him and attempting to depict his single term in office as both underappreciated and unfairly attacked proliferated. …SOURCE

Subscribe to the Isranet Daily Briefing

* indicates required

Please select all the ways you would like to hear from the Canadian Institute for Jewish Research:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

To top